These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Monitoring the pharmacokinetics of pyridinium aldoximes in the body. Kalász H; Furész J; Tekes K Mini Rev Med Chem; 2009 May; 9(5):596-610. PubMed ID: 19456290 [TBL] [Abstract][Full Text] [Related]
4. Reactivators of acetylcholinesterase inhibited by organophosphorus nerve agents. Mercey G; Verdelet T; Renou J; Kliachyna M; Baati R; Nachon F; Jean L; Renard PY Acc Chem Res; 2012 May; 45(5):756-66. PubMed ID: 22360473 [TBL] [Abstract][Full Text] [Related]
5. High-performance liquid chromatographic analysis of imidazolium and pyridinium oximes in plasma and urine. Shih ML; Smith JR; Salem GW J Chromatogr; 1990 May; 527(2):371-9. PubMed ID: 2387884 [TBL] [Abstract][Full Text] [Related]
6. Reactivation of DFP- and paraoxon-inhibited acetylcholinesterases by pyridinium oximes. Oh KA; Park NJ; Park NS; Kuca K; Jun D; Jung YS Chem Biol Interact; 2008 Sep; 175(1-3):365-7. PubMed ID: 18565503 [TBL] [Abstract][Full Text] [Related]
7. Retention behavior of pyridinium oximes on PFP stationary phase in high-performance liquid chromatography. Dohnal V; Musílek K; Kuča K J Chromatogr Sci; 2014 Mar; 52(3):246-51. PubMed ID: 23564057 [TBL] [Abstract][Full Text] [Related]
8. Potent 3-Hydroxy-2-Pyridine Aldoxime Reactivators of Organophosphate-Inhibited Cholinesterases with Predicted Blood-Brain Barrier Penetration. Zorbaz T; Braïki A; Maraković N; Renou J; de la Mora E; Maček Hrvat N; Katalinić M; Silman I; Sussman JL; Mercey G; Gomez C; Mougeot R; Pérez B; Baati R; Nachon F; Weik M; Jean L; Kovarik Z; Renard PY Chemistry; 2018 Jul; 24(38):9675-9691. PubMed ID: 29672968 [TBL] [Abstract][Full Text] [Related]
9. LC-MS/MS approaches for the assay of bis-quaternary pyridinium oximes used as AChE reactivators in biological matrices. Voicu V; Albu F; Tache F; Musilek K; Kuca K; Medvedovici A Bioanalysis; 2013 Apr; 5(7):793-809. PubMed ID: 23534424 [TBL] [Abstract][Full Text] [Related]
10. A new and rapid determination of pyridinium aldoximes in blood and urine. Groff WA; Ellin RI Clin Chem; 1969 Jan; 15(1):72-83. PubMed ID: 5762678 [No Abstract] [Full Text] [Related]
11. Hydrophobicity/hydrophilicity descriptors obtained from extrapolated chromatographic retention data as modeling tools for biological distribution: application to some oxime-type acetylcholinesterase reactivators. Voicu V; Sora I; Sârbu C; David V; Medvedovici A J Pharm Biomed Anal; 2010 Aug; 52(4):508-16. PubMed ID: 20202777 [TBL] [Abstract][Full Text] [Related]
12. The 3,3'-bis-pyridinium mono-oximes as antidotes against organophosphorous intoxication. Sikder AK; Pandey KS; Jaiswal DK; Dube SN; Kumar D; Husain K; Bhattacharya R; Das Gupta S J Pharm Pharmacol; 1992 Dec; 44(12):1038-40. PubMed ID: 1361555 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of Two Chlorine-Substituted Bis-Pyridinium Mono-Aldoximes with Regenerating Effect on Butyrylcholinesterase. Kalász H; Szimrók Z; Karvaly G; Adeghate J; Tekes K Molecules; 2020 Mar; 25(5):. PubMed ID: 32164301 [TBL] [Abstract][Full Text] [Related]
14. Assessment of antidotal efficacy of cholinesterase reactivators against paraoxon: In vitro reactivation kinetics and physicochemical properties. Gupta B; Singh N; Sharma R; Foretić B; Musilek K; Kuca K; Acharya J; Satnami ML; Ghosh KK Bioorg Med Chem Lett; 2014 Oct; 24(19):4743-4748. PubMed ID: 25190468 [TBL] [Abstract][Full Text] [Related]
15. Chromatographic analysis of toxic phosphylated oximes (POX): a brief overview. Becker C; Worek F; John H Drug Test Anal; 2010 Oct; 2(10):460-8. PubMed ID: 20882513 [TBL] [Abstract][Full Text] [Related]
16. Ligand-based 3D QSAR analysis of reactivation potency of mono- and bis-pyridinium aldoximes toward VX-inhibited rat acetylcholinesterase. Dolezal R; Korabecny J; Malinak D; Honegr J; Musilek K; Kuca K J Mol Graph Model; 2015 Mar; 56():113-29. PubMed ID: 25588616 [TBL] [Abstract][Full Text] [Related]
18. Lipophilicity indices derived from the liquid chromatographic behavior observed under bimodal retention conditions (reversed phase/hydrophilic interaction): application to a representative set of pyridinium oximes. Voicu V; Sârbu C; Tache F; Micăle F; Rădulescu ŞF; Sakurada K; Ohta H; Medvedovici A Talanta; 2014 May; 122():172-9. PubMed ID: 24720980 [TBL] [Abstract][Full Text] [Related]
19. The history of cholinesterase reactivation: hydroxylamine and pyridinium aldoximes. Petroianu GA Pharmazie; 2012 Oct; 67(10):874-9. PubMed ID: 23136724 [TBL] [Abstract][Full Text] [Related]